title: Bioengineered strategies for spinal cord repair.
abstract: This article reviews bioengineered strategies for spinal cord repair using tissue engineered scaffolds and drug delivery systems. The pathophysiology of spinal cord injury (SCI) is multifactorial and multiphasic, and therefore, it is likely that effective treatments will require combinations of strategies such as neuroprotection to counteract secondary injury, provision of scaffolds to replace lost tissue, and methods to enhance axonal regrowth, synaptic plasticity, and inhibition of astrocytosis. Biomaterials have major advantages for spinal cord repair because of their structural and chemical versatility. To date, various degradable or non-degradable biomaterial polymers have been tested as guidance channels or delivery systems for cellular and non-cellular neuroprotective or neuroregenerative agents in experimental SCI. There is promise that bioengineering technology utilizing cellular treatment strategies, including Schwann cells, olfactory ensheathing glia, or neural stem cells, can promote repair of the injured spinal cord. This review is divided into three parts: (1) degradable and non-degradable biomaterials; (2) device design; and (3) combination strategies with scaffolds. We will show that bioengineering combinations of cellular and non-cellular strategies have enhanced the potential for experimental SCI repair, although further pre-clinical work is required before this technology can be translated to humans.
authors.affiliation: Toronto Western Research Institute, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Nomura
authors.forename: Charles H
authors.initials: CH
authors.lastname: Tator
authors.forename: Molly S
authors.initials: MS
authors.lastname: Shoichet
mesh_terms: D000818:Animals; D001672:Biocompatible Materials; D001698:Biomedical Engineering; D017690:Cell Transplantation; D004867:Equipment Design; D006801:Humans; D009414:Nerve Growth Factors / Q000627:therapeutic use; D013119:Spinal Cord Injuries / Q000628:therapy*
chemical_list: D001672:Biocompatible Materials; D009414:Nerve Growth Factors